 |
diethylenetriaminepentaacetate (DPTA) |
|---|---|
| Trade Name | |
| Orphan Indication | For treatment of patients with known or suspected internal contamination with plutonium, americium or curium to increase the rates of elimination |
| USA Market Approval | USA |
| USA Designation Date | 2004-04-14 00:00:00 |
| Sponsor | CIS-US;10 DeAngelo Drive;Bedford, Massachusetts, 01730 |
